GERNA Biotech

CAS-FREE GENE EDITING TECHNOLOGY​

At GERNA Biotech, we are pioneering Cas-free gene editing technologies that eliminate the need for Cas proteins, offering safer and more efficient solutions to genetic disorders, and opening new possibilities in genetic therapy.

Advantages of Cas-Free Technology

No Double-Strand Breaks (DSB)

Our Cas-free technology eliminates the risk of double-strand breaks, ensuring safer gene editing.

Less Off-target issue

Using over 30 bp guide-RNA, minimizes off-target effects, enhancing precision.

No PAM Dependency

Without PAM constraints, our design allows for broader and more versatile gene editing applications.

About Us

Our Best Qualities

We know our strong sides and constantly improving our skills and knowledge.
Our GOALs

Capabilities of Our Technology

Short-Term Goals

Gene Therapy
meet unmet needs with innovative gene therapies
Accessible for various genetic disorders such as SNP, MNV, and Deletions
for all individuals suffering from genetic diseases

Mid-Term Goals

Gene Rewind
to reverse mutations acquired through aging and stress
Innovative gene therapy to restore the original state at birth
Rewinding mutations means genetic reverse-aging

Long-Term Goals

Super Gene
Transform regular genes into more efficient and superior forms
Ambitious project to enhance human genetic potential
Definite Preparation for the Future of Humanity
GERNA BIOTECH History

We have been rapidly growing since our establishment!

2022.03
Founded GERNA Biotech
Established with a vision to revolutionize gene therapy, spun off from IBS.
2022.03
2022.03.
Selected for the Youth Startup Academy
Selected for the Youth Startup Academy by the Korea SMEs and Startups Agency (KOSME).
2022.03.
2022.04.
Selected for the Open Lab Project
Selected for the Open Lab Project at Korea University Guro Hospital by the Korea Health Industry Development Institute (KHIDI).
2022.04.
2022.07.
Received Investment!!
Received investment from Daegu Technology Holdings.
2022.07.
2022.08.
Awarded TIPS Project!!
Awarded TIPS project by the Korea Institute of Startup and Entrepreneurship Development (KISED).
2022.08.
2022.10.
Won G-Investment Award!!
Won G-Investment Award from Gyeongbuk Creative Economy Innovation Center.
2022.10.
2023.03.
Secured Development Contract
Secured a development contract from the National Institute of Ecology.
2023.03.
2023.04.
Selected for Scale-Up Support Program
Selected for the Scale-Up Support Program by the Daegu Center for Creative Economy & Innovation (CCEI).
2023.04.
2023.05.
Secured Project
Secured a project from the Open Lab at Korea University Guro Hospital.
2023.05.
2023.06.
Selected for Scale-Up Support Program
Selected for the Scale-Up Support Program by the Daegu CCEI.
2023.06.
2023.06.
Selected for Patent Consulting Project
Selected for the Patent Consulting Project by the KHIDI.
2023.06.
2023.07.
Invited as Guest Company
Invited as a guest company at the opening ceremony of Medi Expo Korea.
2023.07.
2023.07.
Selected for Data Support Program
Selected for the Data Support Program by the Daegu Digital Innovation Promotion Agency.
2023.07.
2023.09.
Secured Development Contract
Secured a development contract from the National Institute of Health.
2023.09.
2023.10.
Presented at International Convention
Presented at the International Research Industry Convention.
2023.10.
2023.11.
Invited to Global Healthspan Summit
Invited to the Global Healthspan Summit hosted by Hevolution Fund of Crown Prince Mohammed bin Salman of Saudi Arabia.
2023.11.
2023.12.
Selected as Member Company
Selected as a member company of S&S LAB (Iris Lab) and opened a corporate research institute at Seongsu Center, Seongdong-gu.
2023.12.
2023.12.
Recognized as Excellent Case
Recognized as an excellent case in the Data Support Program by the Daegu Digital Innovation Promotion Agency.
2023.12.
Contacts

We’d love to hear from you!

If you have any questions or need more information about GERNA Biotech, please feel free to reach out to us.

Address:

913, 456-DongDaeGu-Ro, Dong-gu, Daegu, South-Korea